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Abstract
The classical approach to analyze time-to-event data, e.g. in clinical trials, is to fit
Kaplan-Meier curves yielding the treatment effect as the hazard ratio between treatment
groups. Afterwards commonly a log-rank test is performed in order to investigate whether
there is a difference in survival, or, depending on additional covariates, a Cox proportional
hazard model is used. However, in numerous trials these approaches fail due to the pres-
ence of non-proportional hazards, resulting in difficulties of interpreting the hazard ratio
and a loss of power. When considering equivalence or non-inferiority trials, the commonly
performed log-rank based tests are similarly affected by a violation of this assumption.
Here we propose a parametric framework to assess equivalence or non-inferiority for sur-
vival data. We derive pointwise confidence bands for both, the hazard ratio and the
difference of the survival curves. Further we propose a test procedure addressing non-
inferiority and equivalence by directly comparing the survival functions at certain time
points or over an entire range of time. We demonstrate the validity of the methods by a
clinical trial example and by numerous simulation results.
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1 Introduction
Time-to-event outcomes are frequently observed in medical research, for instance in the area of
oncology or cardiovascular diseases. A commonly addressed issue is the comparison of a test to
a reference treatment with regard to survival. For this purpose an analysis based on Kaplan-
Meier curves (see Kaplan and Meier (1958)), followed by a log-rank test (see, for example,
Kalbfleisch and Prentice (2011)) is still the most popular approach. Additionally, adjusting for
multiple covariates, Cox’s proportional hazards model (Cox (1972)) has been extensively used
in the last decades (for some examples see Cox and Oakes (1984); Klein and Moeschberger
(2006) among many others). In case of addressing non-inferiority or equivalence, extensions
of the log-rank test investigating the vertical distance between the survival curves have been
proposed by Wellek (1993) and Com-Nougue et al. (1993). These approaches owe much of their
popularity to the fact that they do not rely on assumptions on the distribution of event times.
Moreover, a direct interpretation is obtained by summarizing the treatment effect in one single
parameter, given by the hazard ratio of the two treatments, assumed to be constant over time.
However, this assumption has been heavily criticized (see for example Herna´n (2010); Uno et al.
(2014)), and is in practice rarely assessed or even obviously violated (see Li et al. (2015) and
Jachno et al. (2019) for an overview on the awareness of this assumption). In particular if
short- and long-term benefits of the two treatments differ for instance in situations where a
surgical treatment is compared to a non-surgical one (see for example Howard et al. (1997) and
the references therein), the assumption of proportional hazards is questionable and should be
carefully investigated. The most obvious sign for a violation of this assumption are survival
curves crossing each other. However, often other techniques are required, for example graphical
methods (see Grambsch and Therneau (1994) for an overview) or statistical tests (see for
example Gill and Schumacher (1987)).
One of the advantages of the standard methodology based on Kaplan-Meier curves and the
log-rank test is that equivalence hypotheses can be formulated using one parameter, that is
the hazard ratio. If this ratio changes over time, both, an alternative measure of treatment
effect, and a suitable definition of equivalence have to be found. For instance, Royston and
Parmar (2011) introduce the restricted mean survival time to overcome this issue. Moreover,
an alternative to commonly used log-rank based tests of equivalence has been proposed by
Martinez et al. (2017) under the assumption of proportional odds. Further these authors show
that type I errors for a log-rank based test are higher than the nominal level if the assumption
of proportional hazards doesn’t hold. Finally, in a recent paper Shen (2020) proposes an
alternative test for equivalence based on two other non-parametric models, which can also be
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used if neither hazards, nor odds, are proportional.
Methods that employ parametric survival models are less common than the above-mentioned
semi-or non-parametric methods. However, a correctly specified parametric survival model pro-
vides numerous advantages, as for instance more precise estimates (see, for example, Klein and
Moeschberger (2006)) or the possibility of making predictions. Inference based on parametric
models can be very precise even in case of misspecification, as demonstrated by Subramanian
and Zhang (2013), who develop simultaneous confidence bands for parametric survival curves
and compare them to non-parametric approaches based on Kaplan-Meier estimates.
In this paper we develop new methodology in two directions. We address the issue of non-
inferiority and equivalence testing in presence of non-proportional hazards by presenting a
parametric alternative to the classical methodology, without the assumption of a constant
hazard-ratio. We first present an approach to derive pointwise confidence bands for the differ-
ence of two survival curves and the hazard ratio over time, respectively, by both making in-
ference of the asymptotic distribution of these curves and using a bootstrap approach. Second
we use these confidence intervals to assess equivalence or non-inferiority of the two treatments.
Finally all our methods are illustrated by a clinical trial example and by means of a simulation
study.
2 Methods
Consider two samples of size n1 and n2 respectively, resulting in a total sample size of n =
n1 +n2. Let Y1,1, . . . , Y1,n1 and Y2,1, . . . , Y1,n2 denote independent random variables representing
survival times for individuals allocated to two (treatment) groups, observing a time range given
by T = [0, tmax], where 0 denotes the start of the observations. Assume that the distribution
functions F1 and F2 of Y1,j, j = 1, . . . , n1 and Y2,j j = 1, . . . , n2, respectively, are absolutely
continuous with densities f1 resp. f2. Consequently the probability of experiencing an event
for an individual j of the `-th sample before time t can be written as
F`(t) = P(Y`,j < t) =
∫ t
0
f`(u)du, ` = 1, 2.
Further denote the corresponding survival functions by S` := 1 − F` and the hazard rates by
h` :=
f`
S`
. The cumulative hazard function is given by H`(t) = − log(S(t)), ` = 1, 2.
For the sake of simplicity we do not assume additional covariates. Further we assume all
observations to be randomly right-censored and denote the censoring times of the two samples
by C1,1, . . . , C1,n1 and C2,1, . . . , C2,n2 and the corresponding distribution functions by G1 and
G2 respectively. Note that these distributions can differ from each other and are assumed to be
independent from the Y`,j, ` = 1, 2, j = 1, . . . n`. We define ∆`,j = I{Y`,j ≥ C`,j}, indicating
whether an individual is censored (∆`,j = 0) or experiences an event (∆`,j = 1), where I
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denotes the indicator function. Consequently the observed data (t`,j, δ`,j) is a realization of the
bivariate random variable (T`,j,∆`,j), where T`,j = min(Y`,j, C`,j), ` = 1, 2, j = 1, . . . n`. In
order to make inference on the underlying distributions we consider the likelihood function for
group ` given by
L`(F`, G`) =
n∏`
j=1
{
f`(t`,j)
δ`,j(1− F`(t`,j))1−δ`,j
} · n∏`
j=1
{
(1−G`(t`,j))δ`,j(g`(t`,j))1−δ`,j
}
, (2.1)
as censoring times and survival times are assumed to be independent. Hence we can obtain
estimates for the densities f`(t) = f`(θ`, t) and g`(t) = g`(ψ`, t) by deriving the parameters
θˆ` and ψˆ` maximizing logL`, ` = 1, 2. Note that if one is not interested in estimating the
underlying distribution of the censoring times and θ` and ψ` have no common parameters, this
optimization procedure can be further simplified by just considering the first part in (2.1),
resulting in an objective function given by
L˜`(θ`) =
n∏`
j=1
{
f`(θ`, t`,j)
δ`,j(1− F`(θ`, t`,j))1−δ`,j
}
, ` = 1, 2. (2.2)
2.1 Confidence bands
In the following we will construct pointwise confidence bands for the difference of the survival
functions and for the hazard ratio. First we derive an asymptotic approach using the Delta-
method (see Oehlert (1992)) and second, we propose an alternative based on a bootstrap
procedure, where the latter can also be used when samples are very small or, moreover, if
asymptotic inference cannot be made due to the lack of concrete expressions for the variance.
In order to simplify calculations, we will consider the log-ratio and therefore the two measures
of interest are given by
∆(t, θ1, θ2) := S1(t, θ1)− S2(t, θ2) and r(t, θ1, θ2) := log h1(t,θ1)h2(t,θ2) . (2.3)
Under certain regularity conditions (see Bradley and Gart (1962)) the Maximum Likelihood
estimates (MLE) obtained by maximizing (2.1) or (2.2) are asymptotically normally distributed,
that is √
n`
(
θˆ` − θ`
) D−→ N (0, I−1θ` ), ` = 1, 2,
where I−1θ denotes the inverse of the Fisher information matrix. This result can be used to make
inference about the asymptotic distribution of the estimated survival curves. More precisely,
using the Delta-method we obtain for every t > 0
√
n`
(
S`(t, θˆ`)− S`(t, θ`)
) D−→ N (0, ∂
∂θ`
S`(t, θ`)
TI−1θ` ∂∂θ`S`(t, θ`)), ` = 1, 2.
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Consequently an estimate of the asymptotic variance of ∆(t, θ1, θ2) is given by
σˆ2∆ := V ar(∆(t, θˆ1, θˆ2)) =
1
n1
∂
∂θ1
S1(t, θˆ1)
T I−1
θˆ1
∂
∂θ1
S1(t, θˆ1) +
1
n2
∂
∂θ2
S2(t, θˆ2)
T I−1
θˆ2
∂
∂θ2
S2(t, θˆ2),
(2.4)
where Iθˆ` denotes the observed information matrix, ` = 1, 2. For sufficiently large samples
this asymptotic result can be used to construct pointwise lower and upper (1 − α)-confidence
bounds, respectively, by
L∆(t, θˆ1, θˆ2) := ∆(t, θˆ1, θˆ2)− z1−ασˆ∆ and U∆(t, θˆ1, θˆ2) := ∆(t, θˆ1, θˆ2) + z1−ασˆ∆, (2.5)
where z1−α denotes the (1−α)-quantile of the standard normal distribution. More precisely, if
L(t) and U(t) denote the (1 − α) pointwise lower and the (1 − α) pointwise upper confidence
bound, respectively, it holds
lim
n1,n2→∞
P
(
L∆(t, θˆ1, θˆ2) ≤ ∆(t, θ1, θ2)
) ≥ 1− α , lim
n1,n2→∞
P
(
∆(t, θ1, θ2) ≤ U∆(t, θˆ1, θˆ2)
) ≥ 1− α
(2.6)
for all t > 0, where α denotes the prespecified significance level. The construction of pointwise
confidence bands for the log hazard ratio works similarly and the asymptotic variance of r(t)
is given by
σˆ2r : = V ar(r(t, θˆ1, θˆ2)) =
1
n1
· ∂
∂θ1
log h1(t, θˆ1)
T
I−1θ1
∂
∂θ1
log h1(t, θˆ1)
+ 1
n2
· ∂
∂θ2
log h2(t, θˆ2)
T
I−1θ2
∂
∂θ2
log h2(t, θˆ2). (2.7)
Consequently Ld and Ud are given by
Ld(t, θˆ1, θˆ2) := r(t, θˆ1, θˆ2)− z1−ασˆr, Ud(t, θˆ1, θˆ2) := r(t, θˆ1, θˆ2) + z1−ασˆr (2.8)
and it holds for all t > 0 that
lim
n1,n2→∞
P
(
Ld(t, θˆ1, θˆ2) ≤ r(t, θ1, θ2)
) ≥ 1− α and lim
n1,n2→∞
P
(
r(t, θ1, θ2) ≤ Ud(t, θˆ1, θˆ2)
) ≥ 1− α.
A concrete numerical example for calculating the variances in (2.4) and (2.7) and the corre-
sponding confidence bounds assuming a Weibull distribution are deferred to Section 2 in the
Supplemental Material and the finite sample properties for to this scenario are presented in
Section 3.
If sample sizes are rather small or the variability in the data is high, we propose to obtain
estimates for the variances σˆ2∆ and σˆ
2
r by using a bootstrap approach, taking the right-censoring
into account. This approach has the advantage that it can also be used if a formula for the
asymptotic variance is not obtainable, for instance due to numerical difficulties. The following
algorithm explains the procedure for ∆(t0, θ1, θ2) and it can directly be adapted to r(t0, θ1, θ2).
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Algorithm 2.1. (Parametric) Bootstrap Confidence Intervals for ∆(t0, θ1, θ2).
1. Calculate the MLE θˆ` and ψˆ`, ` = 1, 2, from the data by maximizing (2.1).
2(a). Generate survival times y∗`,1, . . . , y
∗
`,n`
from F`(θˆ`), ` = 1, 2. Further generate the corre-
sponding censoring times c∗`,1, . . . , c
∗
`,n`
by sampling from the distributions G`(ψˆ`), ` = 1, 2.
If y∗`,j > c
∗
`,j, the observation is censored (i.e. δ
∗
`,j = 0), j = 1, . . . , n`. The observed data
is given by (t∗`,j, δ
∗
`,j), t
∗
`,j = min(y
∗
`,j, c
∗
`,j), j = 1, . . . , n`, ` = 1, 2.
2(b). Calculate MLE θˆ∗` for the bootstrap sample from the t
∗
`,j, j = 1, . . . , n`, ` = 1, 2, and
calculate the difference of the corresponding survival functions at t0, that is
∆∗ := ∆(t0, θˆ∗1, θˆ
∗
2) = S1(t0, θˆ
∗
1)− S2(t0, θˆ∗2). (2.9)
3. Repeat steps 2(a) and 2(b) nboot times, yielding ∆
∗
1, . . . ,∆
∗
nboot
and calculate an estimate
for the variance σˆ2∆ by
σˆ2∆ =
1
nboot − 1
nboot∑
k=1
(∆∗k − ∆¯∗)2, (2.10)
where ∆¯∗ denotes the mean of the ∆∗i , i = 1, . . . , nboot.
Finally the estimate σˆ2∆ in (2.10) is used to calculate the confidence band in (2.5). Note that the
procedure described in Algorithm 2.1 is a parametric bootstrap as it is based on estimating the
parameters θˆ`, ψˆ`, ` = 1, 2. A non-parametric alternative, given by resampling the observations
(see Efron and Tibshirani (1994)), could also be implemented.
2.2 Equivalence and non-inferiority tests
We are aiming to compare the survival functions of two (treatment) groups which is commonly
addressed by testing the null hypothesis that the two survival functions are identical versus the
alternative that they are differing at any time point (for an overview, see, for example, Klein
and Moeschberger (2006)). More precisely the classical hypotheses are given by
H0 : S1(t, θ1) = S2(t, θ2) for all t ∈ T against H1 : S1(t, θ1) 6= S2(t, θ2) for a t ∈ T .
In some situations one might be more interested in observing non-inferiority of one treatment
among another or equivalence of the two treatments, meaning that we allow a deviation of the
survival curves of a prespecified threshold instead of testing for equality. This can be done for
a particular point in time, say t0, or over an entire interval, say [t1, t2]. We now consider the
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difference in survival at a particular point in time t0. The corresponding hypotheses are then
given by
H0 : S1(t0, θ1)− S2(t0, θ2) ≥ δ against H1 : S1(t0, θ1)− S2(t0, θ2) < δ (2.11)
for a non-inferiority trial observing whether a test treatment is non-inferior to the reference
treatment (which is stated in the alternative hypothesis). Considering equivalence, the hy-
potheses are given by
H0 : |S1(θ1, t0)− S2(θ2, t0)| ≥ δ against H1 : |S1(θ1, t0)− S2(θ2, t0)| < δ. (2.12)
The same questions can be addressed considering the (log) hazard ratio, resulting in the hy-
potheses analogue to (2.11) given by
H0 : log
h1(θ1,t0)
h2(θ2,t0)
≥ ε against H1 : log h1(θ1,t0)h2(θ2,t0) < ε (2.13)
for a non-inferiority trial and
H0 :
∣∣∣log h1(θ1,t0)h2(θ2,t0) ∣∣∣ ≥ ε against H1 : ∣∣∣log h1(θ1,t0)h2(θ2,t0) ∣∣∣ < ε (2.14)
for addressing equivalence. The choice of the margins δ > 0 and ε > 0 has to be verified in
advance with great care combining statical and clinical expertise. From a regulatory point of
view there is no fixed rule but general advice can be found in a guideline of the European
Medicines Agency (EMA). Following recent literature margins δ for the survival difference
are frequently chosen between 0.1 and 0.2, for detailed discussions on that topic we refer to
D’Agostino Sr et al. (2003); Da Silva et al. (2009); Wellek (2010), who also investigate the
correspondence between δ and the hazard ratio threshold ε.
We now use the confidence bounds derived in (2.5) to construct an asymptotic α-level test for
(2.11). More precisely, the null hypothesis concerning non-inferiority in (2.11) is rejected if the
upper bound of the confidence interval is below the equivalence margin, that is
U∆(t0, θˆ1, θˆ2) ≤ δ. (2.15)
Further, rejecting H0 whenever
U∆(t0, θˆ1, θˆ2) ≤ δ and L∆(t0, θˆ1, θˆ2) ≥ −δ (2.16)
yields an equivalence test for the hypotheses in (2.12). According to the intersection-union-
principleBerger (1982), the same (1− α)-confidence bounds L∆(t0, θˆ1, θˆ2) and U∆(t0, θˆ1, θˆ2) are
used for both, the non-inferiority and the equivalence test. The following theorem states that
this yields an asymptotic α-level test.
Theorem 2.2. The test described in (2.16) yields an asymptotic α-level equivalence tests for
the hypotheses in (2.12). More precisely it holds for all t0 ∈ T
lim
n1,n2→∞
PH0(U∆(t0, θˆ1, θˆ2) ≤ δ, L∆(t0, θˆ1, θˆ2) ≥ −δ) ≤ α.
The proof is left to Section 1 in the Supplemental Material and a similar procedure can be
applied for testing the hypotheses in (2.13) and (2.14).
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2.2.1 Comparing survival over entire time intervals
In some situations it might be interesting to compare survival not only at one particular point
in time but over an entire period of time [t1, t2]. For instance, extending the equivalence test
stated in (2.12) to this situation yields the hypotheses
H0 : max
t∈[t1,t2]
|S1(t, θ1)− S2(t, θ2)| ≥ δ against H1 : max
t∈[t1,t2]
|S1(t, θ1)− S2(t, θ2)| < δ (2.17)
and a similar extension can be formulated for the non-inferiority test (2.11) and the tests on
the hazard ratio (2.13) and (2.14), respectively. In this case we reject the null hypothesis in
(2.12) if, for all t in [t1, t2], the confidence bounds L∆(t) and U∆(t) derived in (2.5) are included
in the equivalence region [−δ, δ].
3 Finite sample properties
In the following we will investigate the finite sample properties of the proposed methods by
means of a simulation study. We consider two scenarios corresponding to the choice of a Weibull
distribution of survival times. In a third case we investigate the robustness of our approach by
generating data according to a log-logistic distribution but still fitting a Weibull model. We
assume (randomly) right-censored observations in combination with an administrative censoring
time in both scenarios meaning a fixed time point of last follow-up which we denote by tmax. All
results are obtained by running nsim = 1000 simulations and nboot = 500 bootstrap repetitions.
For all three scenarios we will calculate confidence bands for both the difference of the survival
curves and the log hazard ratio and observe their coverage probabilities. For the difference of
the survival curves, we will investigate the tests on non-inferiority and equivalence proposed
in (2.15) and (2.16), respectively. For this purpose we will vary both, the particular time
point under consideration t0 and the non-inferiority/equivalence margin δ. More precisely we
will consider three different choices for this margin ranging from rather conservative to liberal,
namely δ = 0.1, 0.15 and 0.2. The test concerning the hypotheses formulated in terms of the log
hazard ratio (see (2.13) and (2.17)) is conducted in the same manner, results are omitted here.
In addition to our new method we also evaluate all scenarios using a non-parametric approach as
described in Section 5.2. of Com-Nougue et al. (1993). More precisely we construct confidence
bounds for the difference of two Kaplan-Meier curves by estimating the variance using the
formula by Greenwood (1926). Due to the sake of brevity the latter results will be deferred to
Section 3 of the Supplemental Material.
For the first two scenarios we assume the data in both treatment groups to follow a Weibull
distribution, that is F`(t, θ`) = 1 − exp
{−(t/θ`,2)θ`,1}, ` = 1, 2, where θ`,1 denotes the shape
parameter and θ`,2 the scale parameter corresponding to treatment group ` = 1, 2. We consider
a time range (in months) given by T = [0, 9], where tmax = 9 is the latest point of follow up.
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Figure 1: The three scenarios under consideration used for simulating type I error rates and
coverage probabilites. (a): Survival curves for Scenarios (3.18) and (3.19) with θ1 = (1.5, 3.4),
θ2 ∈ {(1.5, 4.9), (2, 2.5)}. (b): Corresponding hazard rates. (c): Survival curves for Scenario (3.20).
For the first configuration we choose
θ1 = (1.5, 3.4), θ
1
2 = (1.5, 4.9), θ
2
2 = (1.5, 3.7), (3.18)
where θ1 corresponds to the reference model and the second model is varied by its scale param-
eter. Here θ12 is used for investigating the type I errors and coverage probabilities and θ
2
2 for
simulating the power, respectively. As an example, Figure 1(a) displays the survival curves for
a choice of θ12. Both configurations result in a constant log hazard ratio of log (1.5) ≈ 0.4, repre-
senting the situation of proportional hazards. We assume the censoring times to be exponential
distributed and choose the rates of the two groups such that a censoring rate of approximately
25% results, that is a rate of ψ1 = 0.1 for the reference model and rates of ψ
1
2 = 0.09 and
ψ22 = 0.05 for θ
1
2 and θ
2
2, respectively.
In order to investigate the effect of non-proportional hazards we consider a second scenario of
intersecting survival curves, where we keep the reference model specified by θ1 and all other
configurations as above, but vary the parameters of the second model, resulting in
θ1 = (1.5, 3.4), θ
1
2 = (2, 2.5), θ
2
2 = (2, 3.4). (3.19)
Here the choice of θ12 is used for investigating the type I errors and coverage probabilities and
θ22 for simulating the power, respectively. Again, we consider censoring rates of approximately
25% for both treatment groups, meaning a rate of ψ11 = 0.14 and ψ
1
2 = 0.1 for θ
1
2 and θ
2
2,
respectively.
For the third scenario we generate the survival times according to a log-logistic distribution.
More precisely we choose F`(t, θ`) = 1 − 1
1+(t/θ`,1)
−θ`,2 , ` = 1, 2. We now assume the censoring
times to be uniformly distributed on an interval [0, c`], where c` is chosen such that a censoring
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Figure 2: The two scenarios used for simulating the power. (a): Survival curves for Scenarios (3.18)
and (3.19) with θ1 = (1.5, 3.4), θ2 ∈ {(1.5, 3.7), (2, 3.4)}. (b): Corresponding hazard rates.
rate of approximately 20% results, ` = 1, 2. We consider a time range (in months) given by
T = [0, 12] and define the scenario by the set of parameters given by
θ1 = (1.5, 2.6), θ2 = (2.1, 3.9), (3.20)
where θ1 corresponds to the reference model, see Figure 1(c).
3.1 Coverage probabilities
In order to investigate the performance of the confidence bands derived in (2.5) and (2.8) we
consider the scenarios described above for three different sample sizes, that is (n1, n2) = (20, 20),
(n1, n2) = (50, 50) and (n1, n2) = (100, 100), resulting in total sample sizes given by n = 40, 100
and 200, respectively. We choose a nominal level of α = 0.05 and calculate both, the asymptotic
(two-sided) confidence bands obtained by using the Delta method, and the bands based on the
bootstrap described in Algorithm 2.1, which we call in the following asymptotic bands and
bootstrap bands, respectively. Confidence bands were constructed for an equidistant grid of 23
time points ranging from 1.5 to 6 months for the first scenario and for a grid of 14 different
points ranging from 1.5 to 4 months for the second one, respectively. For the investigations
on the situation of misspecification we consider 21 different time points, ranging from 1 to 5
months. For each of these time points we check for all approaches whether or not the true value
is contained in the calculated confidence interval, which finally yields the simulated coverage
probabilities after all simulation runs have been conducted.
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We first consider the two correctly specified scenarios (event distribution of reference and test
group is Weibull and modelled as such). For the first configuration the hazard ratio is constant
over time, for the second it varies between 0.5 and 2 on the grid described above, or, equivalently,
from −0.6 to 0.7 considering the log hazard ratio. The first two rows of Figure 3 summarize
the simulated coverage probabilities for these scenarios. In general it turns out that for both
scenarios and all approaches, i.e. the asymptotic bands and the bootstrap bands for S1 − S2
and log h1
h2
, respectively, the approximation is very precise when sample sizes increase, as the
coverage probabilities are very close to the desired value of 0.95 in this case. Further it becomes
obvious that the confidence bands obtained by estimating the variance by bootstrap (2.10) are
always slightly more conservative than their asymptotic versions (2.4) and (2.7), respectively.
However, considering the bands on S1 − S2 for very small sample sizes, that is n1 = n2 = 20,
the coverage probability lies between 0.91 and 0.94 and hence these bands are slightly anti-
conservative. The bootstrap bands perform slightly better, but still have coverage probabilites
around 0.93 instead of 0.95, see the first column of Figure 3. This effect already disappears
for n1 = n2 = 50 where a highly improved accuracy can be observed. We observe the same
qualitative results for the asymptotic bands for log h1
h2
, whereas the bootstrap bands show a
different behaviour, that is being rather conservative for small sample sizes, but also getting
more precise with increasing sample sizes.
For smaller sample sizes, all confidence bands under consideration vary in their behaviour
over time. This effect gets in particular visible when considering the non-proportional hazards
scenario (3.19), see the second row of Figure 3. The coverage probability of the bands for
S1−S2 start with a very accurate approximation during the first two months but then decrease
to 0.93. This effect can be explained by the fact that in the setting of a very small sample, that
is n1 = n2 = 20, after this period of time only very few patients remain (note that the median
survival for the reference model is given by 2.6 months) and hence the uncertainty in estimating
the variance becomes rather large. The same holds for all bands under consideration, explaining
the decreasing accuracy at later time points.
Finally we consider the scenario of misspecification (3.20). Here the hazard ratio varies from
2.5 to 0.8 over a time from 1 to 5 months, meaning that hazards are non-proportional. The
corresponding coverage probabilities are shown in the third row of Figure 3. It turns out that
the performance is worse than in case of a correctly identified model as the coverage lies between
0.85 and 0.9 and hence below the desired value of 0.95. However, considering S1 − S2, in a
majority of the cases the coverage is above 0.9, even for a small sample size of n = 40, where
the bootstrap approach performs slightly better than the asymptotic analogue. For increasing
sample sizes the coverage, which varies over the time, approximates 0.95, whereas the bands
for log h1
h2
still do not come sufficiently close to this desired value, even for the largest sample
size of n = 200. Consequently we conclude that these bands suffer more from misspecification
than the ones for S1 − S2, where the latter prove to be robust if sample sizes are sufficiently
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large.
3.2 Type I errors
In the following we will investigate type I error rates for the non-inferiority test (2.15) and
the equivalence test (2.16) on the difference of survival curves. We consider a nominal level
of α = 0.05 and different sample sizes, i.e. (n1, n2) = (20, 20), (n1, n2) = (50, 50), (n1, n2) =
(100, 100) and (n1, n2) = (150, 150), resulting in total sample sizes given by n = 40, 100, 200
and 300, respectively. As already indicated by the findings concerning the coverage probability
presented in Figure 3 the difference between asymptotic and bootstrap based bands is very
small, in particular for total sample sizes larger than 50. This becomes also visible in the
performance of the test and hence, for the sake of brevity, we only display the results for the
asymptotic version here.
We start by considering scenario (3.18) and choose θ2 = (1.5, 4.9), such that the difference
curve S2(t)−S1(t) attains values of 0.1, 0.15 and 0.2 at time points 1.6, 2.3 and 4, respectively,
see Figure 1(a). The median survival is given by 3.8 months and 2.7 months, respectively. In
particular we obtain type I errors on the margin of the null hypothesis for every choice of δ.
Table 1 displays the simulated type I errors, configurations not falling under the null hypothesis
are omitted and marked with ” − ”. The first number always corresponds to the equivalence
test, the number in brackets displays the type I error of the non-inferiority test, respectively. It
turns out that the approximation of the level is very precise, for the non-inferiority test (2.15)
in general and for the equivalence test (2.16) for sufficiently large sample sizes. In particular
for settings on the margin of the null hypothesis, that is S2(t0)− S1(t0) = δ, we obtain type I
errors very close to 0.05. Only for very small samples, that is n1 = n2 = 20, the equivalence
test (2.16) is conservative as the obtained type I errors are zero in almost all scenarios under
consideration.
The same arguments hold for the scenario of non-proportional hazards (3.19) with θ2 = (2, 2.5),
see Table 2. All results obtained here are qualitatively the same as the ones for the scenario
above, demonstrating that the presence of a non-constant hazard ratio does not affect the
performance of the test. Concerning (3.20) it turns out that the robustness of the tests with
regard to the type I error strongly depends on the equivalence/non-inferiority margin. A type
I error inflation occurs for the very liberal margin δ = 0.2, whereas for the other choices of δ
the type I error is controlled properly.
Finally we note that the non-parametric non-inferiority test also yields a precise approximation
of the level if sample sizes are sufficiently large. However, the equivalence test is conservative,
in particular for δ = 0.1. The results and a detailed interpretation are deferred to Section 3.1
of the Supplemental Material.
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Figure 3: Simulated coverage probabilities for scenarios (3.18) (first row), (3.19) (second row) and
the scenario of misspecification (3.20) (third row) at different time points for sample sizes of n1 =
n2 = 20, 50, 100 (left, middle, right column). The dashed lines correspond to the confidence bands
for the difference of the survival functions (2.5), the dotted lines to the confidence bands for the log
hazard ratio (2.8). Black lines display the asymptotic bands, red lines the confidence bands based on
bootstrap, respectively.
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(n1, n2) (t0, S2(t0)− S1(t0)) δ = 0.1 δ = 0.15 δ = 0.2
(20, 20)
(1.6, 0.1) 0.000 (0.049) - -
(2.3, 0.15) 0.000 (0.025) 0.000 (0.051) -
(4, 0.2) 0.000 (0.014) 0.000 (0.030) 0.001 (0.061)
(50, 50)
(1.6, 0.1) 0.001 (0.049) - -
(2.3, 0.15) 0.000 (0.014) 0.017 (0.045) -
(4, 0.2) 0.000 (0.005) 0.010 (0.012) 0.047 (0.048)
(100, 100)
(1.6, 0.1) 0.037 (0.037) - -
(2.3, 0.15) 0.000 (0.009) 0.049 (0.041) -
(4, 0.2) 0.000 (0.001) 0.012 (0.006) 0.050 (0.051)
(150, 150)
(1.6, 0.1) 0.054 (0.044) - -
(2.3, 0.15) 0.001 (0.002) 0.037 (0.040) -
(4, 0.2) 0.000 (0.000) 0.003 (0.003) 0.053 (0.048)
Table 1: Simulated type I errors of the non-inferiority test (2.15) (numbers in brackets) and the
equivalence test (2.16) for the scenario of proportional hazards (3.18) with θ2 = (1.5, 4.9) at three
different time points for different sample sizes and equivalence margins. The nominal level is chosen
as α = 0.05. Scenarios not falling under the null hypothesis are marked with ”− ”.
3.3 Power
For investigations on the power we consider the same configurations as given above. We now
observe the scenario of proportional hazards (3.18) such that the difference curve S1(t)− S2(t)
attains values of 0.01, 0.02 and 0.04 at time points 0.7, 1.2 and 2.3, respectively. Hence all
chosen configurations belong to the alternatives in (2.15) and (2.16). Table 3 displays the
simulated power. It turns out that both tests achieve a reasonable power in most settings
under consideration. The power clearly increases with increasing sample sizes and a wider
equivalence/non-inferiority margin δ. For instance, when considering δ = 0.2 the maximum
power is close to or larger than 80% for all sample sizes and both tests.
For the non-proportional hazards scenario (3.19) we consider θ2 = (2, 3.4), resulting in dif-
ferences of 0.01 and 0.04, attained at time points 0.2 and 0.6 (0.01) and 3.2 and 2.7 (0.04),
respectively (see Figure 3). Table 4 displays the simulated power. We observe that the power
of both tests is reasonably high as well and the results are qualitatively the same as the ones
obtained for scenario (3.18). Further it becomes obvious that for later time points but equal
distances between the two survival curves the power decreases, in particular in presence of
small sample sizes. This can be explained by the fact that the remaining subjects become less
with progressing time, resulting in a higher uncertainty after 3 months compared to 0.2 and
0.6 months, respectively. Of note, at 3 months more than half of the subjects experienced an
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(n1, n2) (t0, S1(t0)− S2(t0)) δ = 0.1 δ = 0.15 δ = 0.2
(20, 20)
(1.9, 0.1) 0.000 (0.060) - -
(2.4, 0.15) 0.000 (0.029) 0.000 (0.049) -
(3, 0.2) 0.000 (0.016) 0.000 (0.021) 0.002 (0.061)
(50, 50)
(1.9, 0.1) 0.000 (0.053) - -
(2.4, 0.15) 0.000 (0.011) 0.008 (0.052) -
(3, 0.2) 0.000 (0.003) 0.007 (0.014) 0.048 (0.048)
(100, 100)
(1.9, 0.1) 0.002 (0.057) - -
(2.4, 0.15) 0.000 (0.008) 0.055 (0.055) -
(3, 0.2) 0.000 (0.001) 0.006 (0.006) 0.038 (0.038)
(150, 150)
(1.9, 0.1) 0.043 (0.053) - -
(2.4, 0.15) 0.004 (0.006) 0.041 (0.041) -
(3, 0.2) 0.000 (0.000) 0.005 (0.005) 0.049 (0.049)
Table 2: Simulated type I errors of the non-inferiority test (2.15) (numbers in brackets) and the
equivalence test (2.16) for the scenario of non-proportional hazards (3.19) with θ2 = (2, 2.5) at three
different time points for different sample sizes and equivalence margins. The nominal level is chosen
as α = 0.05. Scenarios not falling under the null hypothesis are marked with ”− ”.
event in this scenario.
In summary we observe a reasonably high power for both tests. The power increases with in-
creasing sample sizes and a wider equivalence margin. Further the presence of non-proportional
hazards does not affect the power, meaning that in both scenarios the results are qualitatively
the same. Finally we also observe that for the non-parametric approach the power is much
smaller than for our new method, in particular for small sample sizes and for the scenario of
non-proportional hazards, which underlines the theoretical findings. Detailed results can be
found in Section 3.1 of the Supplemental Material.
4 Case Study
In the following we investigate a well known benchmark dataset regarding survival analysis.
The data set veteran from Veteran’s Administration Lung Cancer Trial, published in Kalbfleisch
and Prentice (2011) and implemented in the R package survival by Therneau (2020), describes
a two-treatment, randomized trial for lung cancer. In this trial, male patients with advanced
inoperable lung cancer were allocated to either a standard therapy (reference treatment, ` = 1)
or a chemotherapy (test treatment, ` = 2). Numerous covariates were documented, including
time to death for each patient, which is the primary endpoint of our analysis. In total 137
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(n1, n2) (t0, S2(t0)− S1(t0)) δ = 0.1 δ = 0.15 δ = 0.2
(20, 20)
(0.7, 0.01) 0.145 (0.436) 0.512 (0.723) 0.795 (0.880)
(1.2, 0.02) 0.002 (0.227) 0.057 (0.410) 0.303 (0.595)
(2.3, 0.04) 0.000 (0.114) 0.000 (0.208) 0.000 (0.365)
(50, 50)
(0.7, 0.01) 0.553 (0.696) 0.929 (0.943) 0.995 (0.995)
(1.2, 0.02) 0.025 (0.360) 0.501 (0.645) 0.833 (0.870)
(2.3, 0.04) 0.000 (0.187) 0.085 (0.335) 0.460 (0.601)
(100, 100)
(0.7, 0.01) 0.887 (0.906) 0.998 (0.998) 1.000 (1.000)
(1.2, 0.02) 0.388 (0.548) 0.858 (0.875) 0.988 (0.998)
(2.3, 0.04) 0.017 (0.274) 0.486 (0.557) 0.854 (0.861)
(150, 150)
(0.7, 0.01) 0.973 (0.974) 1.000 (1.000) 1.000 (1.000)
(1.2, 0.02) 0.639 (0.703) 0.971 (0.971) 0.999 (0.999)
(2.3, 0.04) 0.236 (0.364) 0.728 (0.736) 0.949 (0.950)
Table 3: Simulated power of the non-inferiority test (2.15) (numbers in brackets) and the equivalence
test (2.16) for the scenario of proportional hazards (3.18) with θ2 = (1.5, 3.7) at three different time
points for different sample sizes and equivalence margins. The nominal level is chosen as α = 0.05.
observations, allocated to n1 = 69 patients in the reference group and n2 = 68 in the test
group, are given.
The R code reproducing the results presented in the following can be found online at https:
//github.com/kathrinmoellenhoff/survival. As our analysis is model-based, we start with
a model selection step. More precisely we split the data into the reference group and the test
group and assume six different distributions, that is a Weibull distribution, an exponential
distribution, a Gaussian distribution, a logistic distribution, a log-normal distribution and a
log-logistic distribution, respectively. We fit the corresponding models separately per treatment
group, resulting in 12 models in total. Finally we compare for each group the six different models
using Akaike’s Information Criterion (AIC, see Sakamoto et al. (1986)). It turns out that for
the group receiving the reference treatment the Weibull and the exponential model provide the
best fits (AICs are given by 749.1, 747.1, 799.9, 794.7, 755.1 and 758.1 in the order of the models
mentioned above) whereas in the test group the log-logistic, the log-normal and the Weibull
model are the best ones (AICs given by 749.1, 750.1 and 751.7, respectively). Therefore we
decide to base our analyses on Weibull models for both groups. However, note that all tests
could also be performed assuming different distributions for each treatment.
For the analysis we now consider the complete likelihood function (2.1) incorporating the dis-
tribution of the censoring times. We assume the censoring times to be exponentially dis-
tributed and maximizing the likelihood (2.1) yields θˆ1 = (4.82, 1.01), ψˆ1 = 0.00063 and
θˆ2 = (4.76, 1.3), ψˆ2 = 0.00046. Figure 4(a) displays the corresponding Weibull models and
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(n1, n2) (t0, S2(t0)− S1(t0)) δ = 0.1 δ = 0.15 δ = 0.2
(20, 20)
(0.2, 0.01) 0.964 (0.964) 0.996 (0.999) 1.000 (1.000)
(0.6, 0.04) 0.372 (0.448) 0.712 (0.712) 0.891 (0.893)
(2.7, 0.04) 0.000 (0.124) 0.000 (0.219) 0.000 (0.297)
(3.2, 0.01) 0.000 (0.179) 0.000 (0.284) 0.000 (0.374)
(50, 50)
(0.2, 0.01) 1.000 (1.000) 1.000 (1.000) 1.000 (1.000)
(0.6, 0.04) 0.637 (0.640) 0.938 (0.938) 0.997 (0.997)
(2.7, 0.04) 0.000 (0.151) 0.047 (0.339) 0.436 (0.563)
(3.2, 0.01) 0.000 (0.258) 0.054 (0.468) 0.481 (0.684)
(100, 100)
(0.2, 0.01) 1.000 (1.000) 1.000 (1.000) 1.000 (1.000)
(0.6, 0.04) 0.818 (0.841) 0.995 (0.995) 1.000 (1.000)
(2.7, 0.04) 0.001 (0.246) 0.442 (0.555) 0.803 (0.833)
(3.2, 0.01) 0.006 (0.406) 0.558 (0.728) 0.869 (0.921)
(150, 150)
(0.2, 0.01) 1.000 (1.000) 1.000 (1.000) 1.000 (1.000)
(0.6, 0.04) 0.927 (0.927) 1.000 (1.000) 1.000 (1.000)
(2.7, 0.04) 0.206 (0.326) 0.678 (0.701) 0.922 (0.928)
(3.2, 0.01) 0.267 (0.553) 0.797 (0.859) 0.903 (0.984)
Table 4: Simulated power of the non-inferiority test (2.15) (numbers in brackets) and the equivalence
test (2.16) for the scenario of non-proportional hazards (3.19) with θ2 = (2, 3.4) at four different time
points for different sample sizes and equivalence margins. The nominal level is chosen as α = 0.05.
the non-parametric analogue given by Kaplan-Meier curves. It turns out that for both treat-
ment groups the parametric and the non-parametric curves are very close to each other. Further
we observe that the survival curves of the two treatment groups cross each other which indi-
cates that the assumption of proportional hazards is not justified here. Indeed, the hazard ratio
ranges from 0.55 to 1.93 from the first time of event (3 days) until the end of the observational
period (999 days) and therefore an analysis using a proportional hazards model is actually not
applicable here. The p-value of the log-rank test is 0.928 and thus does not detect any difference
between the two groups.
We will now perform a similar analysis using the parametric models and the theory derived in
Section 2. For the sake of brevity we will only consider difference in survival, analyses concerning
the (log) hazard ratio can be conducted in the same manner. We consider the first 600 days of
the trial. We set α = 0.05 and calculate lower and upper (1 − α)-pointwise confidence bands
according to (2.5) at several points 0 ≤ t ≤ 600. Estimates of the variance σˆ∆ are obtained
by both, the asymptotic approach and bootstrap as described in Algorithm 2.1, respectively.
Figure 4(b) displays the estimated difference curve ∆(t, θˆ1, θˆ2) = S1(t, θˆ1) − S2(t, θˆ2) and the
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Figure 4: (a): Survival curves (Kaplan-Meier curves and Weibull models) for the veteran data. Solid
lines correspond to the reference group, dashed lines to the test treatment. (b): Difference in survival,
pointwise confidence bands obtained by the asymptotic approach (dashed) and bootstrap (dotted),
respectively, on the interval [40, 600]. The shaded area indicates the equivalence margins with δ = 0.15.
pointwise confidence bands on the interval [0, 600]. It becomes obvious that there is almost no
difference between the two confidence bands, meaning that the asymptotic and the bootstrap
approach yield very similar results here, which can be explained by the rather high sample size
combined with the very low rate of censoring.
We start our analysis considering t0 = 80, which is close to the median survival of both treat-
ment groups. The difference in survival is ∆(80, θˆ1, θˆ2) = 0.047 and the asymptotic confidence
interval is given by [−0.068, 0.163], while the bootstrap yields [−0.067, 0.162]. Note that these
are two-sided 90%-confidence intervals, as we use 95%-upper and 95%-lower confidence bands
for the test decisions. Investigating the hypotheses (2.11) and (2.12) we observe that both, non-
inferiority and equivalence can be claimed for all δ > 0.163 (0.162), respectively. Consequently,
for δ = 0.15, which is indicated by the shaded area in Figure 4(b), H0 cannot be rejected in
both cases, meaning in particular that the treatments cannot be considered equivalent with
respect to the survival at day 80. Figure 4(b) further displays these investigations for δ = 0.15
simultaneously at all time points under consideration. We conclude that the chemotherapy is
non-inferior to the standard therapy after 96 days, as this is the first time point where the
upper confidence bound is smaller than δ = 0.15. The same conclusion can be made concerning
equivalence as for all t in [0, 600], the lower confidence bounds are completely contained in
the rejection region, meaning that they are larger than −δ = −0.15. Concluding we observe
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that considering for instance δ = 0.2, equivalence would be claimed at all time points under
consideration, demonstrating the impact of the choice of the margin.
5 Conclusions
In this paper we addressed the problem of survival analysis in presence of non-proportional
hazards. Here, commonly used methods, as Cox’s proportional hazards model or the log-rank
test, are not optimal and suffer from a loss of power. Therefore we proposed another approach
for investigating equivalence or non-inferiority of time-to-event outcomes based on the construc-
tion of (pointwise) confidence intervals and applicable irrespectively of the shape of the hazard
ratio. We constructed confidence bands for both, the (log) hazard ratio and the difference of the
survival curve proposing two alternatives, one based on asymptotic investigations and the other
on a parametric bootstrap procedure. Both approaches show a similar performance, where the
latter has the advantage that it can be used for very small samples as well and without the
need to calculate the asymptotic variance.
Our approach provides a framework for investigating survival in many ways. Apart from specific
time points entire periods of time can be observed. We demonstrated that the presence of
non-proportional hazards has no effect on the performance of the confidence bands and the
non-inferiority and equivalence test, respectively, which means that they do not depend on this
assumption, providing a much more flexible tool compared to standard methodology.
Our methods are based on the estimation of parametric survival functions, which can be a very
powerful tool once the suitability of the model has been proven. This has to be assessed in
a preliminary study, using for instance model selection criteria as the AIC. We demonstrated
the robustness of our approach even in the case of misspecification. An interesting extension
of the methodology could be given by model averaging which possibly further improves the
performance of the procedures.
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